Open AccessA Randomized Double-Blinded Placebo Controlled Trial of Clazakizumab for the Treatment of COVID-19 Pneumonia With Hyperinflammation*
Author(s) -
Bonnie E. Lonze,
Peter Spiegler,
Russell Wesson,
Nada Alachkar,
Eva Petkova,
Elaina Weldon,
Rebecca A Dieter,
Yang Li,
Max M. Quinn,
Aprajita Mattoo,
Irfana Soomro,
Steven M. Cohen,
Sherry Leung,
Cecilia L Deterville,
B Mark Landrum,
Muhammad Ali,
David J. Cohen,
Andrew L. Singer,
Ayan Sen,
Edward Chong,
Judith S. Hochman,
Andrea B. Troxel,
Robert A. Montgomery
Publication year - 2022
Publication title -
critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.002
H-Index - 271
eISSN - 1530-0293
pISSN - 0090-3493
DOI - 10.1097/ccm.0000000000005591
Subject(s) - medicine , placebo , odds ratio , randomized controlled trial , clinical endpoint , pathology , alternative medicine